Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

News Trending Portfolio

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Acurx Pharmaceuticals (ACXP)

NASDAQ:ACXP

ACXP

Acurx Pharmaceuticals

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Holding ACXP?

Track your performance easily

Link Broker

Acurx Pharmaceuticals (ACXP) Income Statement

123 Followers

Acurx Pharmaceuticals Income Statement

Last quarter (Q3 2024), Acurx Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Acurx Pharmaceuticals's net income was $-2.82M. See Acurx Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	-	-	-	-	$ 0.00	$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	$ 16.44M	$ 14.58M	$ 12.09M	$ 12.81M	$ 4.60M	$ 5.93M
Operating Income	$ -16.44M	$ -14.58M	$ -12.09M	$ -12.81M	$ -4.60M	$ -5.93M
Net Non Operating Interest Income Expense	-	-	-	-	-	-
Other Income Expense	-	-	-	$ -66.50K	-	-
Pretax Income	$ -16.44M	$ -14.58M	$ -12.09M	$ -12.75M	$ -4.60M	$ -5.93M
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -16.44M	$ -14.58M	$ -12.09M	$ -12.75M	$ -4.60M	$ -5.93M
Basic EPS	$ -1.09	$ -1.15	$ -1.12	$ -1.49	$ -0.74	$ -1.24
Diluted EPS	$ -1.09	$ -1.15	$ -1.12	$ -1.49	$ -0.74	$ -1.24
Basic Average Shares	$ 61.52M	$ 12.67M	$ 10.82M	$ 8.54M	$ 8.89M	$ 7.50M
Diluted Average Shares	$ 61.52M	$ 12.67M	$ 10.82M	$ 8.54M	$ 8.89M	$ 7.50M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 16.44M	$ 14.58M	$ 12.09M	$ 12.81M	$ 4.60M	$ 5.93M
Net Income From Continuing And Discontinued Operation	$ -16.44M	$ -14.58M	$ -12.09M	$ -12.75M	$ -4.60M	$ -5.93M
Normalized Income	$ -15.25M	$ -11.52M	-	$ -10.12M	$ -4.60M	$ -5.93M
Interest Expense	-	-	-	-	-	-
EBIT	$ -16.44M	$ -14.58M	$ -12.09M	$ -12.75M	$ -4.60M	$ -5.93M
EBITDA	$ -16.44M	$ -14.58M	$ -12.09M	$ -12.75M	$ -4.60M	$ -5.93M

Currency in USD

Acurx Pharmaceuticals Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing